Sensex, Nifty tank nearly 1% on selling in pharma, IT shares after new Trump tariffs on drugs

Representational image of the Bombay Stock Exchange (BSE) building, in Mumbai | Photo Credit: PTI Benchmark stock indices Sensex and Nifty tumbled nearly 1% on Friday (September 26, 2025), marking their sixth consecutive day of decline, following heavy selling in pharma and IT shares as U.S. President Donald Trump announced 100% duties on pharmaceutical drugs…

Read More

Stock markets fall in early trade on relentless foreign fund outflows, H-1B visa fee concerns

A view of the National Stock Exchange building in Mumbai. | Photo Credit: Getty Images/iStockphoto Equity benchmark indices Sensex and Nifty declined in early trade on Thursday (September 25, 2025) as relentless foreign fund outflows and U.S. H-1B visa fee concerns made investors jittery. Also, a weak trend in global peers drove the domestic equity…

Read More

Glottis Limited fixes IPO price band at ₹120-₹129 per share

Chennai based Glottis Limited, which offers multi-modal integrated logistics solutions, has announced to tap the capital market to raise upto ₹160 crore through a fresh issue of its equity shares and ₹147 crore via Offer for Sale (OFS) by Ramkumar Senthilvel and Kuttappan Manikandan, the Promoter Selling Shareholders. The price band has been fixed between ₹120-₹129 per equity…

Read More

Walmart-backed PhonePe files confidential IPO

Phonepe is part of other payment aggregators like MobiKwik which filed for IPO. File. | Photo Credit: K. Murali Kumar Walmart-backed payments aggregator PhonePe has filed for an Initial Public Offering, according to company spokesperson. “PhonePe Limited has filed the Pre-filed Draft Red Herring Prospectus with SEBI and the Stock Exchanges, under Chapter IIA of…

Read More